SABCS 2024
Advertisement
Dr. Adam Brufsky details to Dr. Karine Tawagi what separates SABCS from other conferences when it comes to breast cancer.
Dr. Karine Tawagi speaks with Dr. Adam Brufsky about notable data presented at SABCS 2024.
Researchers sought to assess the rate of axillary pCR in TNBC patients.
Adding pembrolizumab to conventional neoadjuvant cytotoxic chemotherapy may improve survival outcomes.
Researchers assessed the real-world treatment patterns and clinical outcomes of HER+ BC brain metastases.
Individuals with metaplastic breast cancer (MpBC) show a distinct molecular phenotype.
A study sought to characterize the molecular and immunological features of the androgen receptor in male breast cancer.
People with hereditary cancer pathogenic variants for breast cancer may elect to undergo bilateral mastectomy for prevention.
The combination of tucatinib and alpelisib is both tolerable and effective at treating patients with HER2-positive MBC.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.